IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Krensavage Asset Management, LLC

Q4 2022 Holdings

Filed 2023-02-15 | 12 holdings | $49.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$49.0M177,00499.4%
United Therapeutics Corp(UTHR)COM91307C102$53.4K192,0480.1%
Regeneron Pharmaceuticals(REGN)COM75886F107$43.4K60,1030.1%
Alkermes PLC(ALKS)COMG01767105$36.6K1,401,7830.1%
Exelixis Inc(EXEL)COM30161Q104$34.3K2,138,0390.1%
Enanta Pharmaceuticals Inc(ENTA)COM29251M106$27.7K594,8180.1%
Embecta Corp(EMBC)COM29082K105$25.7K1,017,6570.1%
Cardinal Health Inc(CAH)COM14149Y108$25.6K332,7490.1%
Taro Pharmaceutical IndusCOMM8737E108$18.7K644,6640.0%
Eagle Pharmaceuticals Inc(EGRX)COM269796108$3.4K114,8250.0%
Kodiak Sciences Inc(KOD)COM50015M109$3.3K463,5980.0%
Vanda Pharmaceuticals Inc(VNDA)COM921659108$2.6K345,2900.0%